Ruxolitinib Related Products
Axios Research stands at the forefront of pharmaceutical reference standards ingenuity, providing high quality Ruxolitinib Reference Standards. These include both pharmacopeial and non-pharmacopeial Ruxolitinib impurities, metabolites, stable isotope products, and nitrosamines. Our Ruxolitinib impurity reference standards are essential for pharmaceutical research, aiding in product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They are also used in identifying unknown impurities and evaluating genotoxic potential. Our Ruxolitinib related products are meticulously characterized and come with a comprehensive Certificates of Analysis (COA) and analytical data that comply with regulatory standards.
Ruxolitinib 7-[[2-(trimethylsilyl)ethoxy]methyl] Impurity
![Picture of Ruxolitinib 7-[[2-(trimethylsilyl)ethoxy]methyl] Impurity](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-M03158.jpg?size=256 "Show details for Ruxolitinib 7-[[2-(trimethylsilyl)ethoxy]methyl] Impurity")
M.F.
M.W. 315.45
CAT# AR-M03158
CAS# 941685-27-4
Ruxolitinib 2-(trimethylsilyl)ethoxy)methyl Impurity
M.F.
M.W. 436.64
CAT# AR-R10005
CAS# 941685-39-8
Ruxolitinib Impurity 25 (+)-Dibenzoyltartaric Acid Salt
M.F.
M.W. 794.93
CAT# AR-R11755
CAS# 1236033-04-7
